Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections-Reference-Cited by-同舟云学术

Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections

Published:2021-06-09 Issue:8 Volume:44 Page:402-408
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Ma Weijie,Gong Zimu,Abu-Sbeih Hamzah,Peng Yuanzun,Peng Frederick,Zou Fangwen,Charabaty Aline,Okhuysen Pablo C.,McQuade Jennifer L.,Altan Mehmet,Zhang Hao Chi,Thomas Anusha S.,Wang Yinghong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference16 articles.

1. Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review;Khoja;Ann Oncol,2017

2. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care;Williams;Crit Care,2004

3. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline;Brahmer;J Clin Oncol,2018

4. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group;Puzanov;J Immunother Cancer,2017

5. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea;Shane;Clin Infect Dis,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

2. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

3. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU;Revista Española de Enfermedades Digestivas;2024

4. Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes;The Oncologist;2023-09-18

5. Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2023-04